Cita APA

Feun, L. G., Wangpaichitr, M., Li, Y., Kwon, D., Richman, S. P., Hosein, P. J., & Savaraj, N. (2018). Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma. J Hepatocell Carcinoma.

Citación estilo Chicago

Feun, Lynn G., Medhi Wangpaichitr, Ying-Ying Li, Deukwoo Kwon, Stephen P. Richman, Peter J. Hosein, and Niramol Savaraj. "Phase II Trial of SOM230 (pasireotide LAR) in Patients With Unresectable Hepatocellular Carcinoma." J Hepatocell Carcinoma 2018.

Cita MLA

Feun, Lynn G., et al. "Phase II Trial of SOM230 (pasireotide LAR) in Patients With Unresectable Hepatocellular Carcinoma." J Hepatocell Carcinoma 2018.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.